Skip to main content
. Author manuscript; available in PMC: 2024 Dec 1.
Published in final edited form as: Am J Obstet Gynecol MFM. 2023 Oct 22;5(12):101200. doi: 10.1016/j.ajogmf.2023.101200

Table 5.

Odds Ratios of placental Inflammatory lesions by treatment group

Intent-to-Treat (ITT) N = 1133 Modified Intent-to-Treat (mITT) N = 1013 Median or more visits in the assigned group (M+) N = 660
GPNC vs. IPNC uOR (95% CI) p-value aOR* (95% CI) p-value uOR (95% CI) p-value aOR* (95% CI) p-value uOR (95% CI) p-value aOR* (95% CI) p-value
Maternal Acute or Chronic Inflammatory Lesions 1.22 (0.94 – 1.59) 0.14 1.17 (0.89 – 1.53) 0.26 1.26 (0.95 – 1.67) 0.11 1.22 (0.91 – 1.63) 0.18 1.33 (0.94 – 1.88) 0.10 1.28 (0.90 – 1.82) 0.18
Maternal Acute Inflammatory Lesion(s) 1.11 (0.88 – 1.41) 0.36 1.12 (0.88 – 1.42) 0.36 1.06 (0.82 – 1.36) 0.66 1.08 (0.84 – 1.40) 0.54 0.99 (0.73 – 1.34) 0.94 1.03 (0.75 – 1.41) 0.87
Chronic inflammatory Lesion(s) 1.09 (0.86 – 1.38) 0.46 1.06 (0.83 – 1.34) 0.65 1.04 (0.81 – 1.33) 0.78 1.00 (0.78 – 1.30) 0.98 1.20 (0.88 – 1.62) 0.25 1.14 (0.83 – 1.56) 0.42

uOR: Unadjusted odds ratio, aOR: adjusted odds ratio

*

adjusted for age, BMI, and smoking status before pregnancy. Bolded results indicate p<0.05